3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
4
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Glioma
1
Glioblastoma
1
Fibrosarcoma
1
Interventions
Specimen Handling
5
Biopsy
5
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
3
sodium-iodide symporter
2
ruxolitinib
2
duvelisib
2
cemiplimab
2
X-Rays
2
Vincristine
2
Prednisone
2
Photons
2
Immunoglobulin G
2
Etoposide
2
Doxorubicin
2
Disulfides
2
prednylidene
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Stem Cell Transplantation
1
Standard of Care
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Nivolumab
1
Melphalan
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
selinexor
×
30 days
×
Clear all
No trials found.